HLA-DR Antikörper (Center)
-
- Target Alle HLA-DR Produkte
- HLA-DR
-
Bindungsspezifität
- Center
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HLA-DR Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Produktmerkmale
-
Rabbit polyclonal antibody to HLA-DRB1 (major histocompatibility complex, class II, DR beta 1)
HLA-DR antibody [N2C3] - Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human HLA-DR.
-
anti-HLA-DR (HLA-DR) antibody (FITC)
HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 FITC
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IHC, ISt, StM Wirt: Maus Monoclonal TAL 1B5 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IP Wirt: Maus Monoclonal MEM-12 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC Wirt: Maus Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS Wirt: Maus Monoclonal L243 PE
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IHC, IF, ISt, StM Wirt: Maus Monoclonal SPM289 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, IP Wirt: Maus Monoclonal HL-39 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC, Func Wirt: Maus Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 PE
anti-HLA-DR (HLA-DR) antibody (APC)HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 APC
-
- Applikationshinweise
-
WB: 1:500-1:3000.
Not yet tested in other applications.
Optimal working dilutions should be determined experimentally by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.43 mg/mL
- Buffer
-
0.1M Tris, 0.1M Glycine, 20 % Glycerol ( pH 7).
0.01 % Thimerosal was added as a preservative. - Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Keep as concentrated solution. Aliquot and store at -20°C or below.
Avoid multiple freeze-thaw cycles.
-
- Target
- HLA-DR
- Andere Bezeichnung
- HLA-DR (HLA-DR Produkte)
- Gen-ID
- 3123
-
